Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience

Görner, M.; Brasch, F.; Hirnle, P.; Gehl, H.-B.; Scholtz, L.-U.; Wegehenkel, K.; Sudhoff, Holger

Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience

Görner M, Brasch F, Hirnle P, Gehl H-B, Scholtz L-U, Wegehenkel K, Sudhoff H (2013)
European Journal of Cancer Care 22(5): 648-652.

Zeitschriftenaufsatz | Veröffentlicht | Englisch

Download

Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!

DOI

https://doi.org/10.1111/ecc.12070

Autor*in

Görner, M.; Brasch, F.; Hirnle, P.; Gehl, H.-B.; Scholtz, L.-U.; Wegehenkel, K.; Sudhoff, Holger^UniBi

Einrichtung

Medizinische Fakultät OWL > AG 202 Hals-Nasen-Ohrenheilkunde

Erscheinungsjahr

2013

Zeitschriftentitel

European Journal of Cancer Care

Band

22

Ausgabe

5

Seite(n)

648-652

ISSN

0961-5423

Page URI

https://pub.uni-bielefeld.de/record/2951882

Zitieren

Görner M, Brasch F, Hirnle P, et al. Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care. 2013;22(5):648-652.

Görner, M., Brasch, F., Hirnle, P., Gehl, H. - B., Scholtz, L. - U., Wegehenkel, K., & Sudhoff, H. (2013). Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care, 22(5), 648-652. https://doi.org/10.1111/ecc.12070

Görner, M., Brasch, F., Hirnle, P., Gehl, H.-B., Scholtz, L.-U., Wegehenkel, K., and Sudhoff, Holger. 2013. “Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience”. European Journal of Cancer Care 22 (5): 648-652.

Görner, M., Brasch, F., Hirnle, P., Gehl, H. - B., Scholtz, L. - U., Wegehenkel, K., and Sudhoff, H. (2013). Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care 22, 648-652.

Görner, M., et al., 2013. Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care, 22(5), p 648-652.

M. Görner, et al., “Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience”, European Journal of Cancer Care, vol. 22, 2013, pp. 648-652.

Görner, M., Brasch, F., Hirnle, P., Gehl, H.-B., Scholtz, L.-U., Wegehenkel, K., Sudhoff, H.: Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care. 22, 648-652 (2013).

Görner, M., Brasch, F., Hirnle, P., Gehl, H.-B., Scholtz, L.-U., Wegehenkel, K., and Sudhoff, Holger. “Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience”. European Journal of Cancer Care 22.5 (2013): 648-652.

Daten bereitgestellt von European Bioinformatics Institute (EBI)